Andrew Lee
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- NF-κB Signaling Pathways
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- NF-κB Signaling Pathways 6
-
- Genomics and Chromatin Dynamics 10
- Pluripotent Stem Cells Research 9
- Epigenetics and DNA Methylation 6
- CRISPR and Genetic Engineering 5
- RNA modifications and cancer 5
- RNA Research and Splicing 5
- Co-authors
- S MirrettMelvin P. WeinsteinL. Barth RellerJoseph C. WuS. MunnéJ. GrifoZev RosenwaksJacques Cohen
- Journals
- Journal of Biological Chemistry (4 papers)Cancer Research (3 papers)Blood (3 papers)PLoS ONE (3 papers)Molecules and Cells (2 papers)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Andrew Lee
89 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 140
- Cancer Research 612
- Clinical Biochemistry 227
- Molecular Biology 2.0k
- Genetics 258
- Aging 41
Countries citing papers authored by Andrew Lee
This map shows the geographic impact of Andrew Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Lee more than expected).
Fields of papers citing papers by Andrew Lee
This network shows the impact of papers produced by Andrew Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Lee. The network helps show where Andrew Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2020 | 2 | |
| 10 | Intra-venous Tissue Plasminogen Activator For Acute Central Retinal Artery Occlusion: A First Randomized Controlled Trial | 2011 | 1 |
| 11 | 2011 | 1 | |
| 12 | 2011 | 24 | |
| 13 | 2010 | 68 | |
| 14 | 2010 | 20 | |
| 15 | 2009 | 47 | |
| 16 | 2009 | 376 | |
| 17 | 2008 | 107 | |
| 18 | 2008 | 49 | |
| 19 | 2008 | 166 | |
| 20 | 2006 | 82 |
About Andrew Lee
Andrew Lee is a scholar working on Cancer Research, Molecular Biology, Immunology, Developmental Neuroscience and Oncology, having authored 98 papers that have together received 4.0k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (10 papers), Pluripotent Stem Cells Research (9 papers), NF-κB Signaling Pathways (6 papers), Epigenetics and DNA Methylation (6 papers), CRISPR and Genetic Engineering (5 papers), RNA modifications and cancer (5 papers), RNA Research and Splicing (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). The work is most often cited by research in Cancer Research (612 citations), Clinical Biochemistry (227 citations), Molecular Biology (2.0k citations), Genetics (258 citations) and Aging (41 citations). Andrew Lee has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include S Mirrett, Melvin P. Weinstein, L. Barth Reller, Joseph C. Wu, S. Munné, J. Grifo, Zev Rosenwaks, Jacques Cohen, Yun Shin Chun and Robert C. Robbins. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Blood, PLoS ONE and Molecules and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.